Advertisement

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Improved Turnaround Times | Median time to first decision: 12 days

Research ArticleNeurointervention

Protective Effect of Agmatine on a Reperfusion Model After Transient Cerebral Ischemia: Temporal Evolution on Perfusion MR Imaging and Histopathologic Findings

D.J. Kim, D.I. Kim, S.K. Lee, S.H. Suh, Y.J. Lee, J. Kim, T.S. Chung and J.E. Lee
American Journal of Neuroradiology April 2006, 27 (4) 780-785;

References

  1. ↵
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–87
    CrossRefPubMedWeb of Science
  2. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11
    CrossRefPubMedWeb of Science
  3. The Interventional Management of Stroke Study. Combined intravenous and intra-arterial recanalization for acute ischemic stroke. Stroke 2004;35:904–11
    Abstract/FREE Full Text
  4. ↵
    Zaidat OO, Suarez JI, Sunshine JL, et al. Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. AJNR Am J Neuroradiol 2005;26:880–84
    Abstract/FREE Full Text
  5. ↵
    Traupe H, Kruse E, Heiss WD. Reperfusion of focal ischemia of varying duration: postischemic hyper- and hypo-perfusion. Stroke 1982;13:615–22
    Abstract/FREE Full Text
  6. Gourley JK, Heistad DD. Characteristics of reactive hyperemia in the cerebral circulation. Am J Physiol 1984;246:H52–58
    PubMedWeb of Science
  7. Todd NV, Picozzi P, Crockard HA, et al. Reperfusion after cerebral ischemia: influence of duration of ischemia. Stroke 1986;17:460–66
    Abstract/FREE Full Text
  8. ↵
    Tasdemiroglu E, Macfarlane R, Wei EP, et al. Pial vessel caliber and cerebral blood flow become dissociated during ischemia-reperfusion in cats. Am J Physiol 1992;263:H533–36
    PubMed
  9. ↵
    Tamura A, Asano T, Sano K. Correlation between rCBF and histological changes following temporary middle cerebral artery occlusion. Stroke 1980;11:487–93
    Abstract/FREE Full Text
  10. ↵
    Yonas H, Gur D, Claassen D, et al. Stable xenon-enhanced CT measurement of cerebral blood flow in reversible focal ischemia in baboons. J Neurosurg 1990;73:266–73
    PubMedWeb of Science
  11. ↵
    Marchal G, Young AR, Baron JC. Early postischemic hyperperfusion: pathophysiologic insights from positron emission tomography. J Cereb Blood Flow Metab 1999;19:467–82
    PubMedWeb of Science
  12. ↵
    Li G, Regunathan S, Barrow CJ, et al. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994;263:966–69
    Abstract/FREE Full Text
  13. ↵
    Yang X, Reis D. Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 1999;288:544–49
    Abstract/FREE Full Text
  14. ↵
    Galea E, Regunathan S, Eliopoulos V, et al. Inhibition of mammalian nitric oxide synthases by agmatine: an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996;316 (pt 1):247–49
  15. Abe K, Abe Y, Saito H. Agmatine suppresses nitric oxide production in microglia. Brain Res 2000;872:141–48
    CrossRefPubMedWeb of Science
  16. ↵
    Kim JH, Yenari MA, Giffard RG, et al. Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp Neurol 2004;189:122–30
    CrossRefPubMedWeb of Science
  17. ↵
    Lee SK, Kim DI, Kim SY, et al. Reperfusion cellular injury in an animal model of transient ischemia. AJNR Am J Neuroradiol 2004;25:1342–47
    Abstract/FREE Full Text
  18. ↵
    Dereski MO, Chopp M, Knight RA, et al. The heterogeneous temporal evolution of focal ischemic neuronal damage in the rat. Acta Neuropathol (Berl) 1993;85:327–33
    PubMed
  19. ↵
    Jean WC, Spellman SR, Nussbaum ES, et al. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery 1998;43:1382–97
    PubMedWeb of Science
  20. ↵
    Kirino T. Delayed neuronal death. Neuropathology 2000;20(suppl):S95–97
    CrossRefPubMedWeb of Science
  21. ↵
    Benveniste H, Drejer J, Schousboe A, et al. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984;43:1369–74
    CrossRefPubMedWeb of Science
  22. ↵
    White BC, Sullivan JM, DeGracia DJ, et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 2000;179:1–33
    CrossRefPubMedWeb of Science
  23. ↵
    Beckman JS. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 1991;15:53–59
    PubMed
  24. ↵
    Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke 1997;28:1283–88
    Abstract/FREE Full Text
  25. ↵
    Bowes MP, Rothlein R, Fagan SC, et al. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 1995;45:815–19
    Abstract/FREE Full Text
  26. ↵
    Okubo S, Tanabe Y, Takeda K, et al. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction following ischemia/reperfusion in rabbits: role of delta-opioid receptor. Am J Physiol Heart Circ Physiol 2004 :287:H1786–91. Epub 2004 Jul 1
    Abstract/FREE Full Text
  27. Gottlieb RA, Burleson KO, Kloner RA, et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621–28
    CrossRefPubMedWeb of Science
  28. ↵
    Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996;79:949–56
    Abstract/FREE Full Text
  29. ↵
    Gilad GM, Gilad VH. Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neurosci Lett 2000;296:97–100
    CrossRefPubMedWeb of Science
  30. ↵
    Olmos G, DeGregorio-Rocasolano N, Paz Regalado M, et al. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 1999;127:1317–26
    CrossRefPubMedWeb of Science
  31. ↵
    Zhu MY, Piletz JE, Halaris A, et al. Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells. Cell Mol Neurobiol 2003;23:865–72
    CrossRefPubMedWeb of Science
  32. ↵
    Demady DR, Jianmongkol S, Vuletich JL, et al. Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol Pharmacol 2001;59:24–29
    Abstract/FREE Full Text
  33. ↵
    Takahashi K, Greenberg JH, Jackson P, et al. Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1997;17:1137–42
    CrossRefPubMedWeb of Science
  34. ↵
    Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, et al. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995;21:1465–68
    CrossRefPubMedWeb of Science
  35. ↵
    Kockx MM, Muhring J, Knaapen MW, et al. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol 1998;152:885–88
    PubMedWeb of Science
  36. ↵
    Qureshi AI, Suri MF, Ostrow PT, et al. Apoptosis as a form of cell death in intracerebral hemorrhage. Neurosurgery 2003;52:1041–48
    CrossRefPubMedWeb of Science
  37. ↵
    Hossmann KA. Ischemia-mediated neuronal injury. Resuscitation 1993;26:225–35
    CrossRefPubMedWeb of Science
  38. ↵
    Yu CG, Marcillo AE, Fairbanks CA, et al. Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport 2000;11:3203–07
    PubMedWeb of Science
  39. ↵
    Feng Y, Piletz JE, Leblanc MH. Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 2002;52:606–11
    CrossRefPubMedWeb of Science
  40. ↵
    Gilad GM, Salame K, Rabey JM, et al. Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci 1996;58:PL41–46
  41. ↵
    Anis NA, Berry SC, Burton NR, et al. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 1983;79:565–75
    CrossRefPubMedWeb of Science
  42. ↵
    Church J, Zeman S, Lodge D. The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats. Anesthesiology 1988;69:702–09
    CrossRefPubMedWeb of Science
  43. ↵
    Lees GJ. Halothane anaesthesia reverses the neuroprotective effect of ketamine against ibotenic acid toxicity in the rat hippocampus. Brain Res 1989;502:280–86
    PubMed
  44. ↵
    Warner DS, Ludwig PS, Pearlstein R, et al Halothane reduces focal ischemic injury in the rat when brain temperature is controlled. Anesthesiology 1995;82:1237–45, discussion 1227A
    CrossRefPubMedWeb of Science
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Cite this article
0 Responses
Respond to this article
Bookmark this article
Protective Effect of Agmatine on a Reperfusion Model After Transient Cerebral Ischemia: Temporal Evolution on Perfusion MR Imaging and Histopathologic Findings
D.J. Kim, D.I. Kim, S.K. Lee, S.H. Suh, Y.J. Lee, J. Kim, T.S. Chung, J.E. Lee
American Journal of Neuroradiology Apr 2006, 27 (4) 780-785;
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement